GordonMD Global Investments LP (“the Firm”, or “Adviser”) was established in June 2021 by
Craig Gordon MD who is the managing member of the general partner and majority owner of
GordonMD Global Investments. GordonMD, a Delaware limited liability company, is
headquartered in Beverly Hills, California.
GordonMD Global Investments LP (“GordonMD”) is an alternative asset manager focused on
both private and public companies in the biopharmaceutical, life sciences, biotechnology,
diagnostic and other healthcare-related sectors. GordonMD through its Funds general partners,
(GordonMD Long Biased Fund GP, LLC, and GordonMD PE Fund GP, LLC) collectively referred
to as the Funds ("General Partners”) provides advisory services on a discretionary basis to
privately offered pooled investment vehicles (GordonMD Long Biased Master Fund, LP,
GordonMD Long Biased Fund LP, GordonMD Long Biased Offshore Fund LTD, GordonMD PE
Fund LP, GordonMD PE Offshore Feeder Fund LP) collectively known as the ("Funds") that are
exempt from registration
under the Investment Company Act of 1940, as amended (“1940 Act”)
and whose securities are not registered under the Securities Act of 1933, as amended (“Securities
Act”). Each fund is organized as a limited partnership with an affiliated entity to GordonMD
serving as General Partner. Each General Partner is subject to the Advisers Act of 1940, as
amended, and the rules and regulations promulgated thereunder, pursuant to the Adviser’s
registration in accordance with SEC guidance. This brochure also describes the business practices
of the General Partners, which operates as a single advisory business together with the Adviser
hereafter collectively referred to as “GordonMD.”
GordonMD provides discretionary investment advisory services based on each private Fund’s
investment guidelines as outlined in each Fund’s offering documents.
GordonMD does not participate in wrap fee programs.
As of December 31, 2023, GordonMD managed $176,174,588 in regulatory assets under
management on a discretionary basis.